MTMR通过控制脂质的血膜水平来调节KRAS功能
bioRxiv : the preprint server for biology
|February 8, 2024
概括
肌素相关蛋白质 (MTMR) 通过维持血膜酸素 (PtdSer) 水平来调节KRAS蛋白位址. 沉默MTMR会破坏这个过程,影响癌细胞的增殖和分化.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
背景情况:
- 对于细胞信号传递至关重要的GTPase,KRAS的功能需要血膜 (PM) 结合.
- 克拉斯局部化到PM取决于与酸丁氨酸 (PtdSer) 的相互作用.
研究的目的:
- 为了确定调节KRAS PM局部化的基因.
- 阐明酸丁 (PI) 3-酸酶在KRAS膜结合中的作用.
主要方法:
- 全基因组siRNA屏幕用于识别KRAS PM局部化的调节者.
- 分析PI 4-酸盐 (PI4P) 和PI 3-酸盐 (PI3P) 在响应MTMR沉默时的水平.
- 对PtdSer和ORP5局部化的评估.
主要成果:
- 沉默肌肉管氨酸相关蛋白 (MTMR) 2,3,4 和 7 破坏了 KRAS PM 相互作用.
- MTMR的耗尽减少了PMPI4P,损害了ORP5功能和PM的PtdSer丰富.
- MTMR静音提高了PMPI3P,并降低了PM和总PtdSer水平.
结论:
- MTMR蛋白对于维持KRAS局部化所需的PM PtdSer水平至关重要.
- 产生PMPI,支持PI4P合成和PtdSer丰富,需要MTMRPI的3-酸酶活性.
- MTMR的调节失调会影响KRAS信号,可能会影响癌症的进展.
更多相关视频
相关概念视频
Receptor Tyrosine Kinases
12.9K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.9K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K


